Dimeric 1,4-dihydropyridines as calcium channel antagonists

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Molecular Biology

Background:

• 1,4-dihydropyridines are a class of compounds known for their activity as calcium channel blockers.
• Understanding the structure-activity relationship of these compounds is crucial for developing new therapeutic agents.
• Previous research has focused on the role of the dihydropyridine ring in receptor interaction.

Purpose of the Study:

• To synthesize and evaluate a series of novel 1,n-alkanediylbis(1,4-dihydropyridines) as potential calcium channel ligands.
• To investigate the role of the linker chain length and the second dihydropyridine moiety in receptor binding.
• To determine if these bis-dihydropyridine compounds act by bridging adjacent calcium channel receptors.

Main Methods:

• Synthesis of 1,n-alkanediylbis(1,4-dihydropyridines) with varying linker lengths (n=2, 4, 6, 8, 10, 12).
• Radioligand binding assay using [3H]nitrendipine in intestinal smooth muscle preparations.
• Evaluation of binding activity compared to nitrendipine and analogues lacking the second dihydropyridine nucleus.

Main Results:

• Synthesized bis-dihydropyridine compounds exhibited binding activity comparable to nitrendipine.
• Binding activity was independent of the alkanediyl linker chain length.
• Analogues lacking the second dihydropyridine group or with an inactive phenyl ring showed similar activity.

Conclusions:

• The synthesized 1,4-dihydropyridine ligands do not appear to bridge adjacent calcium channel receptors.
• The primary binding interaction is likely mediated by a single 1,4-dihydropyridine moiety.
• The findings suggest a different mechanism of action for these bis-dihydropyridine compounds compared to bridging ligands.